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Abstract
HIV targets the gut mucosa early in infection, causing immune and epithelial barrier dysfunction 
and disease progression. However, gut mucosal sensing and innate immune signaling through 
mucosal pattern recognition receptors (PRR) during HIV infection and disease progression are not 
well defined. Using the simian immunodeficiency virus (SIV)-infected rhesus macaque model of 
AIDS, we found a robust increase in PRR and inflammatory cytokine gene expression during the 
acute SIV infection in both peripheral blood and gut mucosa, coinciding with viral replication. 
PRR expression remained elevated in peripheral blood following the transition to chronic SIV 
infection. In contrast, massive dampening of PRR expression was detected in the gut mucosa, 
despite the presence of detectable viral loads. Exceptionally, expression of TLR4 and 8 was down 
modulated and diverged from expression patterns for most other TLRs in the gut. Decreased 
mucosal PRR expression was associated with increased abundance of several pathogenic bacterial 
taxa, including Pasteurellaceae members, Aggregatibacter and Actinobacillus, and 
Mycoplasmataceae family. Early anti-retroviral therapy led to viral suppression, but only partial 
maintenance of gut PRR and cytokine gene expression. In summary, SIV infection dampens 
mucosal innate immunity through PRR dysregulation and may promote immune activation, gut 
microbiota changes and ineffective viral clearance.
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Introduction
The gut-associated lymphoid tissue (GALT) is an important early site of HIV replication and 
severe mucosal CD4+ T cell depletion1–4. A stable viral reservoir is established in the gut 
very early in infection that is not eradicated even during long-term suppressive anti-
retroviral therapy (ART)2,5. The loss of mucosal CD4+ T cells, altered T cell homeostasis, 
and epithelial barrier disruption are linked to microbial translocation, chronic immune 
activation and disease progression2,6,7. However, changes in the gut microenvironment 
during early HIV infection are not adequately reflected in the peripheral blood, highlighting 
the importance of the gut mucosal assessments to investigate pathogenic mechanisms.
Chronic HIV infection is characterized by persistent viral replication, unresolved immune 
activation, and progressive decline of immune function2,5,6,8. Despite effective suppression 
of viral replication during long-term ART, it fails to eradicate viral reservoirs and fully 
resolve chronic inflammation2,6,9,10. Increased inflammatory cytokine production and 
altered gut microbiota are reflective of pathogenic effects of chronic HIV infection11–13. 
Signaling through pattern recognition receptors (PRR) in the GI tract drives the sensing of 
pathogens and initiation of innate inflammatory immune responses while maintaining 
immune tolerance to resident gut microbiota. Therefore, it is possible that PRR expression 
and signaling may be exploited by pathogens to invade the gut mucosa. Conversely, the host 
may modulate PRR expression to limit the pathogen-driven inflammation and damage to the 
gut microenvironment. Current understanding is limited on whether HIV infection impairs 
PRR expression and innate immune response at the gut mucosal surfaces.
The human gut microbiota plays an essential role in maintaining immune homeostasis. In 
addition to providing a physical barrier against outgrowth of pathogenic bacteria, 
components of the gut microbiota aid in digestion of nutrients, produce important factors 
that support epithelial growth and barrier function and guide the development of the immune 
system14. Changes in the composition and diversity of gut microbiota have been linked to 
inflammation and disease15. Disruption of the gut microbiota involving increased microbial 
diversity and increased presence of potentially pathogenic bacterial families is reported in 
HIV-infected patients and in SIV-infected non-human primates11–13,16–19. These studies 
primarily focused on the lower GI tract and oral cavity. However, shifts in microbiota 
inhabiting the small intestine engaged in nutrient digestion and absorption have been under-
investigated. Moreover, it is not known whether SIV/HIV infection modulates changes in the 
mucosal expression of receptors that sense microbial products, including PRRs, and whether 
infection-associated changes in PRR expression influence aberrant production of 
inflammatory cytokines as well as gut microbiota composition.
Using the SIV model of AIDS, we found a robust increase in the expression of multiple 
PRRs and associated cytokines in the gut mucosa during early SIV infection that was 
followed by a remarkable dampening of PRR and cytokine gene expression during therapy-
naive chronic viral infection, despite the persistence of high viral loads. In contrast, 
increased PRR expression was maintained in peripheral blood at all stages of infection. The 
exception was for TLRs 4 and 8 whose expression was down modulated or unchanged 
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during SIV infection. Altered PRR expression in SIV infection was associated with changes 
in microbiome diversity and increased immune activation. An early initiation of ART 
resulted in elevated levels of PRR expression and enhanced immune recovery. Our findings 
suggest that modulation of PRR signaling during viral infection may be linked to incomplete 
viral clearance, increased immune activation and decreased microbiome diversity. Therefore, 
PRR signaling and/or microbiota modulation in the gut may be beneficial therapeutic targets 
to reverse the pathological consequences of HIV infection.
Results
Viral replication and CD4+ T cell depletion in peripheral blood and gut mucosa during SIV 
infection
Viral RNA loads were detected in both peripheral blood and jejunum samples during acute 
and chronic stages of pathogenic SIVmac251 infection (Supplemental Table 1 and Figure 
1A). Viral loads averaged 2.8 × 106 copies/ml plasma and 1.5 × 105 copies/Jg total RNA 
from jejunum tissue during acute SIV infection. Average viral loads were reduced to 4.4 × 
104 copies/ml in plasma and to 104 copies/µg total RNA in jejunum tissues during chronic 
SIV infection (Figure 1A, p<0.01 compared with acute infection). Severe CD4+ T cell loss 
was consistently detected in the gut mucosa (9.1 ± 8.4% CD3+ CD4+ cells) during acute SIV 
infection that persisted (4.3 ± 4.1%) through chronic viral infection (Figure 1C). CD4+ T 
cell loss in peripheral blood was progressive in acute (35.8 ± 10.0%) and in chronic 
infection (31.8 ± 19.0%), compared to uninfected controls (52.2%). As previously 
reported20, early initiation of ART (1 week post-SIV infection) resulted in a remarkable 
decrease in viral loads in both plasma and jejunum samples and >80% of CD4+ T cell 
restoration (Supplemental Table 1). Despite having plasma viral loads below detection 
limits, residual viral replication was detected in the gut.
SIVmac1A11, a non-pathogenic viral strain, successfully establishes infection in the host but 
does not cause immunodeficiency21,22. Experimental SIVmac1A11 infection led to low 
levels of viral replication (average 1.9 × 103 copies/Jg total RNA) in the jejunum during 
acute viral infection (Figure 1B). They are significantly lower (~3 log difference) compared 
to those with pathogenic SIVmac251 infection (p<0.05) (Figure 1A). In chronic 
SIVmac1A11 infection, all but one animal had viral loads below the limit of detection.
Increased expression of PRRs in peripheral blood during acute SIV infection that persists 
through chronic infection
We sought to determine whether PRR expression was altered in the peripheral blood during 
the acute and chronic stages of SIV infection. A significant increase in the expression of toll-
like receptor (TLR) 1, 2, 6, 7 and 10 (p<0.05) was seen during chronic SIV infection, as 
compared to uninfected controls (Figure 2A). Expression of cytosolic sensors, RIG-I and 
MDA5 was not significantly altered (Figure 2A). Thus, chronic SIV infection resulted 
increased TLR expression in PBMC.
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Marked increase in PRR expression in the gut during acute SIV infection followed by 
massive dampening during chronic infection
We investigated changes in the expression of PRRs in the gut mucosa during SIV infection. 
A robust increase in the expression of MDA-5 and TLRs 2, 5, 6, 7, 9, and 10 (p<0.05) was 
detected in intestinal tissue during acute SIV infection (Figure 2B). These changes mirrored 
the increased TLR expression observed in peripheral blood samples (Figure 2A). However, 
the expression of these PRRs was substantially higher in the gut than in peripheral blood 
(Figure 2A, 2B). Further, robust expression of TLRs 5 and 9 was seen only in the gut 
mucosal tissues, but not in PBMCs of SIV-infected animals compared to uninfected controls.
During chronic SIV infection, a remarkable dampening of PRRs expression (P<0.05; TLRs 
2, 6, 7, 9, 10) was observed in gut mucosal tissues, when compared to those in acute SIV 
infection (Figure 2B). The dampening of PRR expression occurred despite the persistence of 
viral loads in the gut (Figure 1C, 2B). Among TLRs, endosomal TLR3, TLR7, and TLR9 
are known to detect HIV and SIV nucleic acids. Expression levels of TLR7 and 9 genes 
were markedly increased in the gut during acute infection but decreased to baseline levels 
during chronic infection. In summary, there is discordance between peripheral blood and gut 
mucosal compartments for PRR expression, which was most pronounced during chronic SIV 
infection.
Although majority of the TLRs had a striking increase in their expression levels in the gut 
and peripheral blood, TLR4 and TLR8 had a divergent expression pattern. No increase in 
TLR4 or TLR8 expression in the gut was observed during acute as well as chronic stages of 
SIV infection (Figure 2B). This is surprising considering the presence of viral RNA and 
antigens, as well as, active viral replication in the gut. There was a trend of decreased TLR4 
expression during the acute SIV infection although the values did not reach statistical 
significance. Decreased expression was also observed for TLR4 and TLR8 during the acute 
SIV infection in peripheral blood (Figure 2A).
Preservation of PRR expression in the gut following the early initiation of ART
We found that early initiation of ART during HIV and SIV infection can suppress viral 
replication and restore CD4+ T cells in the gut mucosa6,20,23. In order to determine the 
effects of therapeutic intervention on the restoration of gut innate immune homeostasis, we 
measured the PRR gene expression in jejunum samples from animals that received ART 
during acute SIV infection. As previously reported, the early initiation of ART (at one week 
post-SIV infection) led to suppression of viral RNA loads to very low to undetectable levels 
and resulted in >80% restoration of CD4+ T-cells in the gut, and nearly to pre-infection 
levels in the peripheral blood compared to animals initiating ART during chronic SIV 
infection and therapy-naive SIV infected controls20. Early ART partially prevented the 
dampening of the PRR expression in gut tissues of these animals (Figure 2B). The PRR 
expression profile during therapy was similar to that observed during acute SIV infection. 
These data suggest that early ART was able to partially restore the mucosal sensing and 
response through PRR expression, and this coincided with the suppression of viral loads and 
restoration of mucosal CD4+ T cells.
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Preservation of PRR expression in animals with non-pathogenic SIV1A11 infection
We sought to determine whether dampening of the PRR expression in the gut during chronic 
SIV infection was related to viral loads and pathogenicity of the virus. We determined PRR 
expression in animals infected with non-pathogenic SIVmac1A1121. An increase in the PRR 
expression was detected during acute SIVmac1A11 infection and the trend was similar to 
that during acute pathogenic SIV infection. A significant increase in the expression of TLRs 
2, 3, 4, 5, 9, and RIG-I was detected in SIVmac1A11 infected animals, compared to 
uninfected controls (p<0.05, Figure 2C). During chronic SIVmac1A11 infection, PRR 
expression decreased to the levels comparable to those seen in SIV-negative controls (Figure 
2C). This decline coincided with an effective suppression of viral replication in the gut 
mucosa, suggesting that increased TLR expression during acute viral infection was in 
response to viral loads. These findings are in contrast to our findings from pathogenic 
chronic SIVmac251 infection that showed decreased gut mucosal PRR expression in spite of 
persistent viral replication and detectable viral loads, further validating the dysregulation of 
mucosal TLR expression during pathogenic SIV infection (Figure 2B and 2C).
PRR expression of RIG-I or TLR3 negatively correlates with SIV replication
To further investigate whether expression of PRR plays a role in the suppression of viral 
replication, we performed correlation analyses. Among these PRRs, only expression of RIG-
I or TLR3 displayed a significant negative correlation with SIVmac251 loads (Figure 3A). 
Both viral nucleic acid sensors RIG-I and TLR3 were previously shown to inhibit HIV or 
SIV replication24,25. Rapid induction of RIG-I and TLR3 during acute SIV infection 
suggests that the virus was detected by these PRRs. In contrast, there was no correlation of 
any PRRs, including RIG-I or TLR3, with SIVmac1A11 replication (Figure 3B), indicating 
that induction of RIG-I or TLR3 during acute SIVmac1A11 infection might have partly 
contributed to effective suppression of SIVmac1A11 replication.
Inflammatory cytokine expression reflects changes in PRR expression during SIV infection
To determine whether changes in PRR expression during SIV infection were also 
accompanied by associated mucosal responses, we measured the expression of inflammatory 
and immune-modulatory cytokines. There was a significant increase (p<0.05) in the 
expression of the pro-inflammatory cytokines TNFα, IL-12, IL-8, and IL-22 in the 
peripheral blood (Figure 4A) and IFNα, IFNγ, TNFα, IL-12, IL-8, IL-17, IL-22, and IL-23 
in the jejunum compartments (Figure 4B) of animals with acute SIV infection, as compared 
to uninfected controls. The magnitude of the induction of inflammatory cytokines in the gut 
mucosa was substantially greater than that seen in peripheral blood.
Cytokines induced during acute SIV infection (IFNγ, IFNα, TNFα, IL-17, IL-12, IL-8, and 
IL-22) were significantly down-modulated in the gut during the transition from acute to 
chronic SIV infection. Nevertheless, IL-8, IFNγ, and IL-22 levels remained elevated 
compared to SIV-negative controls (Figure 4B). In contrast to the gut, the expression of 
cytokines remained elevated in the peripheral blood during both acute and chronic SIV 
infection (Figure 4A). Initiation of ART during early SIV infection resulted in the control of 
viral replication and an elevated level of several cytokines involved in immune response.
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Expression of pro-inflammatory cytokines was also increased in non-pathogenic 
SIVmac1A11-infected animals during acute infection and was similar to the profile seen 
during SIVmac251 infection (Figure 4B, 4C). However, cytokine expression was reduced to 
basal levels during chronic SIV1A11 infection that was comparable to uninfected controls. 
No demonstrable change in the expression of anti-inflammatory cytokine IL-10, was seen 
during acute or chronic SIVmac251 infection while IL-10 expression was elevated during 
chronic SIV1A11 infection. Collectively, these data indicate that the elevated PPR 
expression induced during SIV infection was associated with inflammatory cytokine 
expression, and that early ART did not decrease levels of both PRR and inflammatory 
cytokines to the basal control levels in the gut mucosa, possibly due to the residual viral 
replication.
SIV infection leads to changes in the gut microbiota
Recent studies have reported alterations in the composition and complexity of gut microbial 
communities during chronic HIV and SIV infections11–13,16–18. Based on the differential 
kinetics of PRR and cytokine expression in intestinal mucosa during SIV infection, we 
sought to investigate whether the pro-inflammatory environment during SIV infection would 
cause alterations in the gut microbiota from the same sites of PRR and cytokine analyses. In 
contrast, most of the previous studies of gut microbiota during HIV and SIV infections 
evaluated fecal samples. To determine the changes occurring in the gut microbiota during 
SIV infection, we constructed and sequenced 16S amplicon libraries from gut tissue of SIV-
infected animals and healthy SIV-negative controls. Gut microbial communities differed 
from one animal to another (Figure 5A). Microbiota from jejunum samples of all the animals 
predominantly consisted of three phyla: Firmicutes, Bacteroidetes, and Proteobacteria 
(Figure 5A). The most notable change during acute SIV infection was a significant increase 
in the levels of Proteobacteria (Figure 5B). A decrease in Firmicutes levels was also detected 
during both acute and chronic SIV infection; although not statistically significant (Figure 
5B). The abundance of Bacteroidetes was comparable between SIV-negative controls and 
SIV infected animals, and there was no detectable difference in the remaining phyla.
Few changes were observed at lower bacterial taxonomic levels. Within the Proteobacteria 
phylum, Pasteurellaceae family members, including Aggregatibacter and Actinobacillus, 
became more abundant during acute SIV infection and then significantly less abundant 
during the chronic viral infection (Figure 6). A significant increase in the abundance of 
Mycoplasmataceae, a family within the Tenericutes phylum, was also detected during 
chronic infection compared with uninfected animals (Figure 6). No significant changes were 
observed within other phyla. However, there was a decreased trend (p =0.08) for 
Streptococcus abundance during acute and chronic infection, and for increased abundance of 
Staphylococcus abundance only in the chronic SIV infection that approached significance 
(Figure 6).
Alterations in gut microbiota correlate with aberrant cytokine and PRR expression
To investigate whether changes in the microbiome of SIV-infected animals could be directly 
associated with expression of specific PRRs or cytokines, we examined correlations between 
the most abundant OTUs (>0.5% in all samples) and expression of PRR and cytokine genes 
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during SIV infection (Figure 7A). We found that Aggregatibacter abundance was positively 
correlated with the expression of TLR1, TLR6, and IL-12, but negatively correlated with 
IL-22 expression. Members of this genus are known to possess virulence factors that inhibit 
activation and function of immune cells26. Similarly, the abundance of organisms belonging 
to the genus Staphylococcus positively correlated with inflammatory cytokines and PRRs, 
including IL-8, IL-12, IL-17, TLR7, and RIG-I, and the abundance of Oxalobacteraceae 
negatively correlated with the expression of IFNγ and TLR10 (Figures 7B–C). Our data 
suggest that shifts in bacterial composition and abundance may influence changes in the 
expression of PRRs and cytokines in the gut during SIV infection.
Discussion
A complex interplay exists among immune cells, intestinal epithelium, and microbial 
communities in the maintenance of gastrointestinal homeostasis. Previous studies have 
demonstrated that disruption of the gut epithelial barrier during chronic HIV and SIV 
infections may contribute to microbial translocation, increased T cell turnover and systemic 
immune activation7,2,4,8,11,27,28. These pathogenic changes may be initiated early in 
infection and be driven by severe loss of mucosal CD4+ T cells1,2930. Although majority of 
HIV infections occur through mucosal routes, a significant number of new HIV infections 
occur following an intravenous exposure of the virus3,5. Rhesus macaques infected with SIV 
through either mucosal route or intravenous exposure progress to acute and chronic stages of 
infection and demonstrate similar levels of severe CD4+ T cell depletion, altered T cell 
homeostasis and increased inflammatory cytokines in the gut29–32. Our study highlights the 
role of the early innate sensing and response through TLR signaling in SIV infection and 
potential implications in viral pathogenesis. Our findings suggest that SIV infection causes a 
rapid up-regulation of PRR and cytokine gene expression in the gut mucosa during acute 
SIV infection. However, these increases are markedly diminished during the chronic viral 
infection. The PRR and cytokine gene expression were associated with changes in the gut 
microbiota. Thus, we identified a potential link between SIV infection associated PRR-
mediated innate immune modulation and microbial dysbiosis. One of the striking 
observations in our study was the discordance between the peripheral blood and gut mucosal 
compartments regarding the induction of PRR and cytokine expression during SIV infection. 
Cells from the peripheral blood are known to be functionally and phenotypically different 
from the cells that reside in the gut, and this may affect the differential PRR expression and 
cytokine responses in the peripheral blood versus the gut mucosal compartment.
Robust changes in PRR gene expression in the gut during early viral infection can originate 
from direct engagement of the receptors with PRR ligands, increased pro-inflammatory 
cytokines, or through altered distribution of mucosal cell populations33. Our findings show 
induction of massive innate immune response in the gut mucosa during acute SIV infection 
that was reflected by a robust increase in the expression of TLR7, TLR9, MDA5, and RIG-I, 
and by relatively modest increase in TLR3 expression. In agreement with previously 
reported studies regarding these PRRs inhibiting HIV or SIV replication25,34, we also found 
that in vivo expression of RIG-I and TLR3 negatively correlated with the replication of 
pathogenic SIVmac251, but not with non-pathogenic SIVmac1A11. While the induction of 
RIG-I or TLR3 expression could dampen SIV replication, the virus may disarm the innate 
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immune signaling during chronic SIV infection. Modest changes in TLR3 levels in our study 
could be possibly due to the whole tissue analysis which may mask increased TLR 
expression localized to a small proportion of responding mucosal cells. Although TLR7 
agonist could possibly reactivate latent SIV reservoirs (James Whitney et al. Abstract #108, 
CROI, 2015), we did not find a correlation of TLR7 expression with SIV replication. 
Engagement of TLR7 was shown to elicit an anergic state in human CD4+ T cells, which 
contributes to CD4+ T cells hyporesponsiveness35. These observations highlight the need for 
further investigations prior to applying TLR agonists in HIV cure study. We recently 
reported an induction of TLR4, TLR7 and TLR8 expression in the gut mucosa during very 
early SIV infection (at 2.5 days following SIV infection)36. This coincided with an increase 
in IL-1β expression and disruption of epithelial barrier36. Collectively, our data suggest that 
SIV induces robust TLR expression in the gut immediately following the viral exposure. 
Thus, early mucosal response to the viral infection is driven by the robust TLR expression 
and may set the stage for the immune dysfunction.
Expression of TLRs 4 and 7 in the gut mucosa was decreased during acute SIV infection 
compared to uninfected animals, and remained unchanged during chronic viral infection. 
Since TLR4 is involved in activating innate immunity and HIV specific cytotoxic T 
lymphocyte activity, impaired TLR4 expression may adversely affect virus-specific 
immunity. This is noteworthy since the decreased TLR4 expression in the gut mucosa 
suggests that it may lead to ineffective anti-viral immune response. Impairment of TLR4 
expression could be a direct effect of viral antigens. HIV tat is shown to cause decreased 
TLR4 expression37. A widespread suppression of genes regulating innate immunity, 
including LPS receptors, CD14 and TLR4 was shown in PBMC of cynomolgus monkeys 
during acute SHIV 89.6p infection38. We also found that TLR8 expression in the gut mucosa 
was not changed during acute and chronic SIV infection despite the presence of viral loads. 
TLR8 is known to sense viral single stranded RNA and induce innate immune response. 
Decreased TLR8 expression was correlated with increased HIV replication in dendritic cells 
in vitro39. Interestingly, the modulation of TLR8 signaling is mediated through the 
complement system and has resulted in enhanced HIV infection, suggesting this as an 
important viral mechanism of immune evasion40. Thus, the virus may highjack innate 
immunity in the gut mucosa through suppression of TLR4 and TLR8. Our findings suggest 
that agonists of these TLRs should be explored for enhancing anti-viral immunity.
We found a remarkable increase in TLR2 and TLR5 expression during acute SIV infection 
in the gut. These data suggest an early encroachment of bacteria into lamina propria, and 
consequent microbial stimulation of intestinal immune cells. Substantial dampening of 
TLR2 and TLR5 expression during chronic infection was surprising, because acute SIV 
infection is associated with disruption of gut epithelial barriers and increased microbial 
translocation, indicating a possible negative feedback regulation of TLR2/5 signaling and/or 
changes of gut microbiota diversity2,3.
The increased TLR expression in the gut during acute SIV infection coincided with up-
regulation of several inflammatory cytokines, including TNFα and IFNγ, which may 
contribute to viral control either by killing infected cells or by modulating other immune 
cells. Following the transition to chronic SIV infection, there was a precipitous decline in the 
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expression of PRRs and cytokines in the gut mucosa. In contrast, the levels of PRRs and 
cytokines in the peripheral blood remained elevated during chronic SIV infection. Changes 
in the expression of inflammatory cytokines in the intestinal mucosa during chronic HIV 
infection have been previously reported41. We found that antigen-presenting cells from 
peripheral blood of individuals with chronic HIV infection showed aberrant inflammatory 
cytokine responses to the commensal bacteria, which was in part due to elevated expression 
of TLR2 on these cells42. It is not fully understood why the gut mucosa experiences 
precipitous dampening of the PRR and cytokine expression during chronic SIV infection 
despite the ongoing viral replication. First, it is possible that the severe depletion of CD4+ T 
cells in the gut and altered T cell homeostasis may cause changes in the PRR expression. 
Disruption of the gut epithelium and its renewal during SIV and HIV infections may also 
impact on the TLR expression. Secondly, SIV or HIV antigens could inhibit the innate 
immune response that would enable viral replication and persistence43. Third, during 
chronic viral infection, changes in the gut microbiota composition may down-modulate 
expression of PRRs (Figure 7) and the associated inflammatory cytokines. Reduced PRR 
expression during chronic SIV infection may compromise the ability of gut immune cells to 
sense and respond to the virus itself as well as to other pathogens, while dampening of PRR 
and cytokine expression in the gut may limit the gut tissue damage caused by chronic 
inflammation.
We found that the initiation of ART during early SIV infection resulted in preservation of 
higher PRR and cytokine expression in the gut (Figures 2B and 4B), and led to effective 
suppression of viral replication, high recovery of CD4+ T cells and induction of mucosal 
repair/renewal associated gene expression in the gut as compared to those initiating ART 
during chronic infection20,23. However, early ART failed to completely suppress viral 
replication or eradicate the virus. Lack of total recovery of the gut mucosal immune 
compartment and PRR expression may be reflective of residual viral replication and immune 
activation as well as microbial translocation in the mucosa. Previous report indicates that 
very early ART in the acute SIV/HIV infection has limited effect on eradication of viral 
reservoirs, which may be associated with dampened PRR-cytokine signaling44.
The non-pathogenic SIVmac1A11 successfully establishes infection in the host but does not 
cause immunodeficiency21,22. The acute SIV1A11 infection elicited an increase in PRR and 
cytokine gene expression levels in the gut that was similar to the increase observed during 
acute SIVmac251 infection. However, PRR and cytokine expression levels decreased during 
chronic SIVmac1A11 infection, which were similar to those in uninfected controls. 
Previously, we found that dissemination and tissue localization of pathogenic SIVmac251 
was very different from non-pathogenic SIVmac1A11, which may be associated with 
increased migration of inflammatory cells into the intestinal mucosa45. Together, these 
findings suggest that, unlike pathogenic SIVmac251, infection with non-pathogenic 
SIVmac1A11 might not cause epithelial damage and microbiota translocation. Alternatively, 
SIVmac1A11-induced gut epithelial damage might be repaired during chronic viral 
infection.
We found that gut microbiota from SIV-infected macaques showed decreased abundance of 
Firmicutes and increased abundance of Proteobacteria. Similar findings have been 
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previously reported in HIV-infected patients11–13,16. Administration of sevelamer, which 
binds to microbial LPS, reduced immune activation in SIV infected macaques46. However, 
sevelamer failed to decrease circulating LPS or soluble CD14 levels in ART-naive HIV 
infected patients47. These findings suggest that blocking of LPS in circulation alone was not 
sufficient to completely resolve immune activation. Thus, further investigations are needed 
to develop strategies to reverse changes in the gut microbiota during pathogenic infections.
To date, most studies have examined colon contents and fecal samples for assessing changes 
in gut microbiota. However, recent studies have clearly showed that composition and 
diversity of microbiota in various parts of the gastrointestinal tract (including small and large 
intestine) are somewhat different. These differences may be driven by the local 
microenvironment that may differ in its pH, oxygen, carbon, ions and minerals and 
microbial exposures. Our study focused on the small intestine where the majority of the 
terminal nutrient digestion and absorption occurs and HIV and SIV infections cause gut 
epithelial barrier disruption, nutrient malabsorption and severe CD4+ T cell 
depletion1,4,27,29,30,32. We examined changes in the gut microbiota from the small intestine 
in order to investigate correlations of the mucosal TLR expression and inflammation with 
gut microbiota changes at the same local site in the gut microenvironment.
Altered microbiota composition could be responsible for changes in PRR expression in the 
gut, leading to increased recognition of the commensal microbiota, resulting in progressive 
inflammation and dysbiosis. Alternatively, the increased expression of PRR and 
inflammatory cytokines could mediate changes of the microbiota composition, also resulting 
in progressive inflammation and dysbiosis. Consistent with this possibility, an increased 
prevalence of Proteobacteria is usually observed in intestinal inflammation because the 
inflamed gut provides new sources of nutrients for bacterial species within this phylum48. 
Furthermore, PRR signaling could be positively or negatively selected for specific taxa49. In 
this regard, we observed several associations between gut microbiota and PRR and cytokine 
expression. For example, Aggregatibacter, which has been previously shown to induce 
TLR2 expression, was positively associated with TLR1, TLR6 and IL-12 expression 
(Figures 7B–C). It is known that TLR2 signaling occurs via heterodimerization with either 
TLR1 or TLR6 and that heterodimers can sense a wide range of molecules mainly from 
Gram-positive, but also from Gram-negative bacteria, generating an inflammatory milieu33. 
The increased abundance of Aggregratibacter coupled with increased TLR1/2/6 expression 
suggests a link between local inflammation and dysbiosis during acute SIV infection. 
Moreover, the abundance of Staphylococcus correlates with several cytokines and PRR. 
These results are also consistent with previous reports that highlight the ability of members 
of this genus to induce the production of inflammatory cytokines50.
Our study captures the in vivo gut mucosal response to SIV infection and highlights changes 
in PRR and cytokine gene expression, as well as their potential effects on the resident gut 
microbiota. Early ART partially restored PRR and cytokine expression in the gut. Future 
studies on the functionality of individual cell subsets such as macrophages, dendritic cells, 
or intestinal epithelial cells will help define their role in the innate gut immune response 
during early infection. A better understanding of HIV-induced PRR signaling and its impact 
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on the innate immune responses is critical to the development of improved therapeutic 
strategies for viral suppression and enhanced immune recovery.
Methods
Animal subjects, infection, and sample collection
The study involved a cross-sectional analysis of samples of jejunum and peripheral blood 
mononuclear cells from rhesus macaques infected intravenously with either pathogenic 
SIVmac251 or non-pathogenic SIVmac1A11 (Supplemental Table 1). Tissue samples were 
collected at necropsy, and immediately cryopreserved −80 °C, during acute (at 1 and 2 
weeks following SIVmac251 or SIVmac1A11 infection) or chronic stages (at 10 to 34 
weeks post-SIVmac251 infection and at 8 to 23 weeks post-SIV1A11 infection) of SIV 
infection as well as from SIV-negative healthy controls. Tissue samples were also obtained 
from rhesus macaques that started receiving combination anti-retroviral therapy (PMPA and 
FTC) at 1 week post-SIVmac251 infection and continued for 30 weeks thereafter as 
previously reported20.
Cell isolation and flow cytometry
Peripheral blood mononuclear cells (PBMC) from peripheral blood and lamina propria 
lymphocytes (LPL) from gut tissue samples were isolated as previously described31,36. Flow 
cytometric analysis was performed to assess the prevalence of CD3+CD4+ T cells using T 
cell phenotype markers CD3 (SP34-2, BD Bioscience) and CD4 (OKT4, eBioscience) as 
previously described36. Isolated PBMC and gut tissue samples were flash frozen in liquid 
nitrogen and cryopreserved for further analysis.
RNA isolation and gene expression analysis
50 mg of frozen tissues and pelleted cryopreserved PBMC were used for RNA extraction 
using RNeasy kit (Qiagen, Valencia, CA). Quantitative real-time PCR (qRT-PCR) was 
performed to measure RNA levels of TLR and cytokine genes as previously reported28. 
Levels of gene transcription were normalized to GAPDH or β-actin, and data were expressed 
as a relative fold change from uninfected controls (Supplementary Information). SIV RNA 
loads in plasma and gut tissue samples were determined by real-time PCR assay as 
described previously31,36.
Gut microbiota analysis
DNA was isolated from jejunal tissue samples using PowerSoil kit protocol (MoBio), 
amplified using a nested PCR protocol and barcoded primer specific for V4 region of 16S 
rRNA and quantified. Sequences were generated (MiSeq Sequencer, Illumina), filtered for 
quality and analyzed using QIIME software. Details are provided in the Supplementary 
information.
Statistical analysis
Statistical differences between groups were analyzed using ANOVA with Tukey post-test on 
normalized Ct values. Spearman correlation coefficients were determined by calculating 
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using normalized Ct values. Differences in microbial abundance were analyzed using non-
parametric Mann-Whitney U tests. Correlation analysis and heatmaps were performed with 
the R Statistical Software.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
Viral loads and CD4+ T cell depletion in peripheral blood and gut mucosal compartments 
during SIV infection. Viral RNA loads were measured in the plasma and gut tissue during 
acute and chronic stages of pathogenic SIV mac251 (A) and nonpathogenic SIVmac1A11 
(B) infection by RT-qPCR. Percentages of CD3+CD4+ T cells were determined by flow 
cytometry (C). Statistical analysis was performed by comparison with uninfected controls. *, 
p<0.05; **, p<0.01.
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Figure 2. 
Expression profiles of pattern recognition receptors during acute and chronic stages of SIV. 
The PRR gene expression was determined by qRT-PCR in the PBMC (A) and gut tissue (B) 
during acute or chronic (therapy-naive or with ART) stages of SIVmac251 infection 
compared to SIV-negative healthy controls. The PRR expression was measured in gut 
samples during the acute and chronic stages of non-pathogenic SIVmac1A11 infection (C). 
Data are shown as the average fold changes compared to uninfected controls. *p<0.05 (red 
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asterisk), compared with uninfected control animals; *p<0.05 (black asterisk), compared 
with chronically infected animals.
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Figure 3. 
A correlation of pattern recognition receptor expression with viral replication during acute 
SIV infection. Spearman rank correlations were performed between expression levels of 
TLR3, TLR7, TLR9 and RIG-I and intestinal viral loads from SIVmac251 (A) and 
SIVmac1A11 (B) infected animals.
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Figure 4. 
Changes in the cytokine expression during acute and chronic stages of SIV infection. 
Cytokine gene expression was analyzed in the PBMC (A) and gut tissue (B) during acute 
and chronic (therapy-naive or with ART) stages of pathogenic SIV infection compared to 
SIV-negative controls using qRT-PCR. Cytokine gene expression was measured in gut tissue 
during acute and chronic stages of non-pathogenic SIVmac1A11 infection (C). The data are 
shown as an average fold change compared to SIV-negative controls. *p<0.05 (red asterisk), 
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compared with uninfected control animals; *p<0.05 (black asterisk), compared with 
chronically infected animals.
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Figure 5. 
SIV infection induced changes in gut microbiota. The gut microbiota from jejunum tissue 
samples of SIV infected macaques were sequenced for 16S amplicons. Data from animals 
during the acute (n=6) and chronic SIV infection (n=19) were compared to those from SIV-
negative healthy controls (n=7). (A) Bar charts represent the group average percentage of the 
total filtered reads that aligned to the indicated phylum. (B) Relative abundance of 
Proteobacteria, Bacteroidetes, and Firmicutes in SIV-negative and SIV-infected macaques 
during acute and chronic stages of infection.
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Figure 6. 
An increased abundance of potentially pathogenic microbial taxa during SIV infection. Dot 
plots show relative abundance of Aggregatibacter, Actinobacillus, Mycoplasmataceae, 
Gemellaceae, Streptococcus, and Staphyclococcus in SIV-negative and SIV-infected 
animals. Significant differences between groups were determined using non-parametric 
Mann-Whitney U tests (p-value ≤ 0.05).
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Figure 7a
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Figure 7b
Figure 7. 
Correlation of the expression of PRRs and cytokines with changes in the gut microbiota 
during SIV infection. (A) A heatmap of Spearman correlation coefficients was generated for 
abundance of microbial families and relative expression of pattern recognition receptors and 
cytokines in the gut during SIV infection. The red color indicates a positive correlation 
coefficient and the blue color represents a negative coefficient. Significant correlations 
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(unadjusted p-value≤ 0.05) were indicated with an asterisk. Spearman rank correlations 
between TLR (B) and Cytokines (C) expression and abundance of the most abundant OTUs.
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